Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors
Zbigniew Dutkiewicz, Renata Mikstacka
Bioinorganic Chemistry and Applications (2018) Vol. 2018, pp. 1-21
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Reece G. Kenny, Celine J. Marmion
Chemical Reviews (2019) Vol. 119, Iss. 2, pp. 1058-1137
Closed Access | Times Cited: 528
Structure-Based Virtual Screening: From Classical to Artificial Intelligence
Eduardo Habib Bechelane Maia, Letícia C. Assis, Tiago Alves de Oliveira, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 444
Virtual Screening Algorithms in Drug Discovery: A Review Focused on Machine and Deep Learning Methods
Tiago Alves de Oliveira, Michel Pires da Silva, Eduardo Habib Bechelane Maia, et al.
Drugs and Drug Candidates (2023) Vol. 2, Iss. 2, pp. 311-334
Open Access | Times Cited: 57
The Multifarious Link between Cytochrome P450s and Cancer
Abdullah M. Alzahrani, Peramaiyan Rajendran
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 70
Tryptophan metabolism-related gene CYP1B1 serves as a shared biomarker for both Parkinson’s disease and insomnia
Xinyu Li, Wen-Kai Yu, Jinghao Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Evaluating the potential of Kalanchoe pinnata, Piper amalago amalago, and other botanicals as economical insecticidal synergists against Anopheles gambiae
Sheena Francis, William Irvine, Lucy Mackenzie-Impoinvil, et al.
Malaria Journal (2025) Vol. 24, Iss. 1
Open Access
Molecular Docking Study and 3D-QSAR Model for Trans-Stilbene Derivatives as Ligands of CYP1B1
Zbigniew Dutkiewicz, Renata Mikstacka
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1002-1002
Open Access
Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks
Jong-Won Kim, Hung‐Chun Tung, Bin Yang, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100045-100045
Closed Access
Molecular Architect: A User-Friendly Workflow for Virtual Screening
Eduardo Habib Bechelane Maia, Lucas Rolim Medaglia, Alisson Marques da Silva, et al.
ACS Omega (2020) Vol. 5, Iss. 12, pp. 6628-6640
Open Access | Times Cited: 39
In Silico ADME Profiling of Salubrinal and Its Analogues
Pavlo V. Zadorozhnii, Vadym V. Kiselev, Александр В. Харченко
Future Pharmacology (2022) Vol. 2, Iss. 2, pp. 160-197
Open Access | Times Cited: 22
CYP1A inhibitors: Recent progress, current challenges, and future perspectives
Ziru Dai, Yue Wu, Yuan Xiong, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 1, pp. 169-234
Closed Access | Times Cited: 12
Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy
Vinay R. Sonawane, Mohd Usman Mohd Siddique, Surender Singh Jadav, et al.
European Journal of Medicinal Chemistry (2019) Vol. 165, pp. 115-132
Closed Access | Times Cited: 39
CYP1B1 gene: Implications in glaucoma and cancer
Arwa Alsubait, Wadha Aldossary, Mamoon Rashid, et al.
Journal of Cancer (2020) Vol. 11, Iss. 16, pp. 4652-4661
Open Access | Times Cited: 38
Blueberry and/or Banana Consumption Mitigate Arachidonic, Cytochrome P450 Oxylipin Generation During Recovery From 75-Km Cycling: A Randomized Trial
David C. Nieman, Nicholas D. Gillitt, Guan‐Yuan Chen, et al.
Frontiers in Nutrition (2020) Vol. 7
Open Access | Times Cited: 35
Design, Synthesis, biological investigations and molecular interactions of triazole linked tacrine glycoconjugates as Acetylcholinesterase inhibitors with reduced hepatotoxicity
Harmandeep Kaur Gulati, Sushil Choudhary, Nitish Kumar, et al.
Bioorganic Chemistry (2021) Vol. 118, pp. 105479-105479
Closed Access | Times Cited: 22
Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect
Gera Narendra, Shalki Choudhary, Baddipadige Raju, et al.
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 11, pp. 1495-1517
Closed Access | Times Cited: 15
New Perspectives of CYP1B1 Inhibitors in the Light of Molecular Studies
Renata Mikstacka, Zbigniew Dutkiewicz
Processes (2021) Vol. 9, Iss. 5, pp. 817-817
Open Access | Times Cited: 19
Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds
Louis K. S. Darko, Emmanuel Broni, Dominic S. Y. Amuzu, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1796-1796
Open Access | Times Cited: 18
CYP35 family in Caenorhabditis elegans biological processes: fatty acid synthesis, xenobiotic metabolism, and stress responses
Sharoen Yu Ming Lim, Mustafa Ahmed Alshagga, Cin Kong, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 12, pp. 3163-3174
Closed Access | Times Cited: 13
Inhibition of human CYP1 enzymes by a classical inhibitor α‐naphthoflavone and a novel inhibitor N‐(3, 5‐dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study
Risto O. Juvonen, Elmeri M. Jokinen, Adeel Javaid, et al.
Chemical Biology & Drug Design (2020) Vol. 95, Iss. 5, pp. 520-533
Closed Access | Times Cited: 17
In silico characterization of the psilocybin biosynthesis pathway
William Irvine, Marshall Tyler, Rupika Delgoda
Computational Biology and Chemistry (2023) Vol. 104, pp. 107854-107854
Closed Access | Times Cited: 5
Complex chemical signals dictate Ah receptor activation through the gut–lung axis
Fangcong Dong, Iain A. Murray, Andrew J. Annalora, et al.
The FASEB Journal (2023) Vol. 37, Iss. 7
Open Access | Times Cited: 5
Discovery of 4’-trifluoromethylchalcones as novel, potent and selective hCYP1B1 inhibitors without concomitant AhR activation
Yue Wu, Jin-Hui Shi, Guanghao Zhu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115552-115552
Closed Access | Times Cited: 5
PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY
Jackson A. Pereira, Eduardo Damasceno Costa
INDIAN DRUGS (2024) Vol. 61, Iss. 02, pp. 23-34
Closed Access | Times Cited: 1
Virtual screening and zebrafish models in tandem, for drug discovery and development
D. Hernández-Silva, Francisca Alcaraz‐Pérez, Horacio Pérez‐Sánchez, et al.
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 8, pp. 903-915
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top